BMI Over 27 With Weight-Related Conditions Patients with a BMI of 27 kg/m or above may also be considered if they have weight-related health conditions, such as: Type 2 diabetes High blood pressure High cholesterol or triglycerides Fatty liver risk Sleep apnea Insulin resistance Cardiovascular risk factors This follows the general medical approach used for prescription weight management treatments, where eligibility is based on both BMI and health risknot appearance alone
Gastrointestinal side effects, including nausea, vomiting, and diarrhea, are extremely common with GLP-1 therapy and may exacerbate nutritional deficits while directly contributing to feelings of unwellness and fatigue
Ongoing Monitoring & Support Throughout the treatment, Dr
The FDA has advised patients to be cautious about compounded GLP-1 drugs, emphasizing that it does not evaluate these medications for safety, quality, or efficacy before theyre sold
Which Blood Tests Might Show Semaglutide Effects
If you prefer to plan your meals around appetite suppression, morning injection may work better